StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Chlorquinbis(phosphat)

Chloroquine Phosphate

HCID 64927
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
50-63-5
Standard-SMILES
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O
InChIKey
QKICWELGRMTQCR-UHFFFAOYSA-N
Summenformel
C18H32ClN3O8P2
Durchschnittliche Molmasse
515,9 g/mol
Monoisotopische Masse
515,1353167

Überblick

Chloroquine Phosphate is the phosphate salt of chloroquine, a quinoline compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids.

Namen und Bezeichner

Bevorzugter Name
Chloroquine Phosphate
IUPAC
4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid
Lokaler Name
Chlorquinbis(phosphat)
Englischer Name
Chloroquine diphosphate
Summenformel
C18H32ClN3O8P2
Molmasse
515.86

Namen und Synonyme

Chloroquine diphosphateChloroquine phosphateAralen phosphateArechinAvloclorResochinChingamin phosphateDelagilChloroquini phosphasNSC-140506E17K3343PSN-7618
Weitere Namen anzeigen
CHLOROQUIN PHOSPHATECHLOROQUINE DIPHOSPHATE SALTwr1522alermineh-stadurkhingaminMelatonine2klorokinfosfatChloropicrin 1
WR-15227-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline phosphate (1:2)1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2)N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine, phosphate (1:2)khingamin phosphateNSC14050MalarivonChloroquinum Phos.

Datenbank-Bezeichner

CAS
50-63-5
PubChem CID
64927
DTXSID
DTXSID7044681
ChEMBL
CHEMBL58510

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
184 Ų
H-Brücken-Donoren
7
H-Brücken-Akzeptoren
11
Frei drehbare Bindungen
8
Schwere Atome
32
Formalladung
0
Komplexität
358

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Anti-infective Agents; Antiparasitic Agents; Antimalarials; Antirheumatic Agents; Antiprotozoal Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsFDA approved animal drugs -> Active ingredient
Collision Cross Section175.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
200 °C · 200 °C (dec.) (lit.)
Dampfdruck
1e-7 kPa · <0.0000001 kPa ( 25 °C)
storage temp.
protect from light
Löslichkeit
2 O: · H2O: 50 mg/mL, clear
Aggregatzustand
solid
pka
8.1 · pKa 8.10(H2O t = 20 c = 0.0025) (Uncertain)
Farbe
White
PH

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Gefahrenhinweise

Other Safety InformationIMAP assessments - 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2): Environment tier I assessment

Toxikologische Informationen

Treatment · 1 Eintrag

Treatment is symptomatic and must be prompt with immediate evacuation of the stomach by emesis (at home, before transportation to the hospital) or gastric lavage until the stomach is completely emptied. If finely powdered, activated charcoal is introduced by stomach tube, after lavage, and within 30 minutes after ingestion of the antimalarial, it may inhibit further intestinal absorption of the drug. To be effective, the dose of activated charcoal should be at least five times the estimated dose of chloroquine ingested. Convulsions, if present, should be controlled before attempting gastric lavage. (L1712)

Health Effects · 1 Eintrag

Possible heath effects include an irreversible retinal damage, visual disturbances, nyctalopia; scotomatous vision with field defects of paracentral, pericentral ring types, and typically temporal scotomas, nerve type deafness; tinnitus, reduced hearing in patients with preexisting auditory damage. Other effects include pleomorphic skin eruptions, skeletal muscle myopathy, hypotension, electrocardiographic change as well as neuropsychiatric changes including psychosis, delirium, personality changes and depression (RxList, A308).

Exposure RoutesInhalation Completely absorbed from gastrointestinal tract
Toxicity Summary · 1 Eintrag

The mechanism of plasmodicidal action of chloroquine is not completely certain. Like other quinoline derivatives, it is thought to inhibit heme polymerase activity. This results in accumulation of free heme, which is toxic to the parasites. nside red blood cells, the malarial parasite must degrade hemoglobin to acquire essential amino acids, which the parasite requires to construct its own protein and for energy metabolism. Digestion is carried out in a vacuole of the parasite cell. During this process, the parasite produces the toxic and soluble molecule heme. The heme moiety consists of a porphyrin ring called Fe(II)-protoporphyrin IX (FP). To avoid destruction by this molecule, the parasite biocrystallizes heme to form hemozoin, a non-toxic molecule. Hemozoin collects in the digestive vacuole as insoluble crystals. Chloroquine enters the red blood cell, inhabiting parasite cell, and digestive vacuole by simple diffusion. Chloroquine then becomes protonated (to CQ2+), as the digestive vacuole is known to be acidic (pH 4.7); chloroquine then cannot leave by diffusion. Chloroquine caps hemozoin molecules to prevent further biocrystallization of heme, thus leading to heme buildup. Chloroquine binds to heme (or FP) to form what is known as the FP-Chloroquine complex; this complex is highly toxic to the cell and disrupts membrane function. Action of the toxic FP-Chloroquine and FP results in cell lysis and ultimately parasite cell autodigestion. In essence, the parasite cell drowns in its own metabolic products.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Completely absorbed from gastrointestinal tract. Chloroquine is partially metabolized; the major metabolite is desethylchloroquine. Desethylchloroquine also has antiplasmodial activity, but is slightly less active than chloroquine. Bisdesethylchloroquine, which is a carboxylic acid derivative, and several other unidentified metabolites are also formed in small amounts (A625). Route of Elimination: Excretion of chloroquine is quite slow, but is increased by acidification of the urine. Half Life: 1-2 months

FDA Pharmacological Classification · 4 Einträge

CHLOROQUINE PHOSPHATE

Antimalarial [EPC]

CHLOROQUINUM PHOS.

Antimalarial [EPC]

MeSH Pharmacological Classification · 3 Einträge

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)

Pharmacological agents destructive to nematodes in the superfamily Filarioidea.

Verwendung und Herstellung

UsesFor the suppressive treatment and for acute attacks of malaria due to P. vivax, P.malariae, P. ovale, and susceptible strains of P. falciparum, Second-line agent in treatment of Rheumatoid Arthritis (A308).
Household ProductsInformation on 1 consumer products that contain Chloroquine phosphate in the following categories is provided:

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
UNII
6E17K3343P
pH(100g/l, 25℃) : 3.8~4.3
Biologische Quelle
synthetic
Wasserlöslichkeit
Soluble in water
Merck
14 · 14,2163
BRN
4223142 · 4223142
BCS Class
1 · 1
Stabilität
2 years · Stable for 2 years from date of purchase as supplied. Solutions in distilled water may be stored at -20° for up to 3 months.
InChI
1S/C18H26ClN3.2H3O4P/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;2*1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);2*(H3,1,2,3,4)
InChIKey
QKICWELGRMTQCR-UHFFFAOYSA-N
SMILES
OP(O)(O)=O.OP(O)(O)=O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
CAS Datenbank
50 · 50-63-5(CAS DataBase Reference)
EPA chemische Informationen
Chloroquine diphosphate (50-63-5)
Signs and SymptomsConvulsive seizures. Mild and transient headache.
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Chloroquine phosphate

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Sicherheitsdaten

F
10
wgk
3
ridadr
1544
hs_code
2933492250
RTECS-Nr.
VB2450000
risk_code
22-40-20/21/22
Toxizität
LD50 oral in rat: 623mg/kg
hazard_code
Xn
safety_code
22-24/25-36
hazard_class
6.1(b)
packing_group
III
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral
Anwendungen · 1 Eintrag

VerwendenChloroquine diphosphate salt is used to study the role of endosomal acidification in cellular processes, such as the signaling of intracellular TLRs. It can be used as DNA intercalator & to dissociate antigen antibody complexes without denaturing red blood cell antigens. Chloroquine showed very high antiviral activity against NiV but very little activity against the other viruses at concentrations lower than 20 μM.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

4-Aminopentyldiethylamin4,7-DichlorchinolinOrthophosphorsure